Solutions
Discover how our solutions bring compliance through innovation
Imaging platforms
Digitize & automate Microbiology QC
Applications
Compliance through innovation
Software
Connecting all the dots
Mission & vision
Team
Jobs
Contact
23 July 2025
Share with:
In pharmaceutical microbiology quality control (QC), precision isn’t optional—it’s regulated. Yet many laboratories still rely on manual or semi-manual plate reading processes that introduce variability, slow down workflows, and complicate compliance.
Enter a new generation of automated microbiology QC solutions—where artificial intelligence, digital workflows, and audit-ready data converge. At the forefront of this shift is EMMA, Microtechnix’s AI-assisted system designed to standardize plate reading, reduce variability, and ensure full traceability in GMP environments.
Microbiology QC labs face a familiar set of challenges:
Traditional plate reading methods rely heavily on the human eye, making reproducibility difficult—especially across operators, labs, and time. This variability directly impacts trend analysis, contamination control strategies, and ultimately product release decisions.
EMMA redefines plate reading automation by combining advanced imaging, vision AI, and compliant software into a single integrated platform.
At its core, EMMA uses a patented optical system that captures 100% of the Petri dish surface—including sidewalls—without removing the lid, eliminating contamination risk while ensuring complete data capture.
This high-quality image acquisition feeds into AI-powered analysis that:
The result: consistent, reproducible plate readings, independent of operator variability.
One of EMMA’s most significant advantages is its ability to eliminate variability at the source.
Through a proprietary calibration system, EMMA ensures that every instrument produces identical, standardized images across sites and over time.
Combined with AI-driven analysis, this enables:
In practice, this means microbiology teams can move from subjective interpretation to data-driven, validated decision-making.
In regulated environments, automation alone isn’t enough—compliance is critical.
EMMA addresses this with a fully digital workflow designed around data traceability and audit trails:
Every action—from image acquisition to result interpretation—is recorded, creating a transparent and inspection-ready audit trail.
This level of traceability ensures that QA and validation stakeholders can confidently demonstrate compliance during audits and inspections.
Modern quality control systems for microbiology labs must work within broader digital ecosystems.
EMMA is designed with interoperability in mind:
By connecting imaging, analysis, and reporting, EMMA enables true microbiology workflow automation—reducing manual transcription errors and accelerating review processes.
Beyond accuracy and compliance, EMMA delivers operational efficiency:
This combination of speed and standardization allows labs to handle increasing sample volumes without compromising quality.
EMMA represents more than just an incremental improvement—it’s a shift toward fully digitized, AI-assisted microbiology QC.
By integrating:
…it enables pharmaceutical manufacturers to meet both operational and regulatory demands with confidence.
As regulatory expectations around data integrity continue to rise, microbiology labs can no longer rely on manual processes that introduce variability and risk.
EMMA provides a future-ready solution—transforming microbiology QC into a standardized, automated, and fully traceable workflow.
For QC leaders and QA stakeholders in GMP environments, this means:
In short, EMMA is setting the benchmark for automated microbiology QC solutions—bringing consistency, compliance, and clarity to one of the most critical processes in pharmaceutical manufacturing.